Karyopharm Expanded Access Program for Selinexor

Clinical trial NCT07215832 · AVAILABLE

Trial details

NCT number: NCT07215832
Sponsor: Karyopharm Therapeutics Inc
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Multiple Myeloma Diffuse Large B-Cell Lymphoma (DLBCL)Sarcoma Neuroglioblastoma Peripheral T-cell Lymphoma Endometrial Cancer Myelofibrosis Other

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.